Abstract:A new strain of influenza A (H1N1) virus is a major cause of morbidity and mortality around the world. The neuraminidase of the influenza virus has been the most potential target for the anti-influenza drugs such as oseltamivir and zanamivir. However, the emergence of drug-resistant variants of these drugs makes a pressing need for the development of new neuraminidase inhibitors for controlling illness and transmission. Here a 3D structure model of H1N1 avian influenza virus neuraminidase type 1 (N1) was constructed based on the structure of the template H5N1 avian influenza virus N1. Upon application of virtual screening technique for N1 inhibitors, two novel compounds (ZINC database ID: ZINC02128091, ZINC02098378) were found as the most favorable interaction energy with N1. Docking results showed that the compounds bound not only in the active pocket, but also in a new hydrophobic cave which contains Arg368, Trp399, Ile427, Pro431 and Lys432 of N1. Our result suggested that both of the screened compounds containing the hydrophobic group bring a strong conjugation effect with Arg293, Arg368 Lys432 of N1 by pi-pi interaction. However, the control inhibitors zanamivir and oseltamivir do not have this effect. The details of N1-compound binding structure obtained will be valuable for the development of a new anti-influenza virus agent.

Synthesis and Structure-Activity Relationship Study of Arylsulfonamides As Novel Potent H5N1 Inhibitors.

Design And Synthesis Of Heteroaromatic-Based Benzenesulfonamide Derivatives As Potent Inhibitors Of H5n1 Influenza A Virus

Design, Synthesis and Biological Evaluation of Small Molecular Polyphenols As Entry Inhibitors Against H(5)N(1).

Structure-aided Optimization of 3-O-β-chacotriosyl Ursolic Acid As Novel H5N1 Entry Inhibitors with High Selective Index.

Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus.

Structure-Aided Optimization of 3-O-β-chacotriosyl Epiursolic Acid Derivatives As Novel H5N1 Virus Entry Inhibitors.

Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase

Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.

Potent Inhibitor Design Against H1N1 Swine Influenza: Structure-Based and Molecular Dynamics Analysis for M2 Inhibitors from Traditional Chinese Medicine Database.

Discovery of the first series of small molecule H5N1 entry inhibitors.

Studies on synthesis and structure-activity relationship (SAR) of derivatives of a new natural product from marine fungi as inhibitors of influenza virus neuraminidase.

Synthesis, evaluation and structure-activity relationship studies of pterodontic acid acylated derivatives with anti-flu A virus (H1N1) activity in vitro

Rational Design and Optimization of Acylthioureas As Novel Potent Influenza Virus Non-Nucleoside Polymerase Inhibitors.

Structure-Based Design, Synthesis and Anti-Influenza A Virus Activities of Substituted Phenyl-Coupled Heterocyclic Ethylamide Derivatives

Incorporation of Privileged Structures into 3-O-β-chacotriosyl Ursolic Acid Can Enhance Inhibiting the Entry of the H5N1 Virus.

Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors

Discovery of Aryl Benzoyl Hydrazide Derivatives As Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (Rdrp)

Discovery of a Series of Novel Compounds with Moderate Anti-Avian H5N1 Influenza Virus Activity in Chick Embryo

A Novel Class of Potent Influenza Virus Inhibitors: Polysubstituted Acylthiourea and Its Fused Heterocycle Derivatives.

Synthesis and Preliminary Biologic Evaluation of 5‐substituted‐2‐(4‐substituted Phenyl)‐1,3‐benzoxazoles As A Novel Class of Influenza Virus A Inhibitors

Synthesis and Biological Evaluation of Analogs of Methyl Ursolate 3-O-β-chacotrioside As H5N1 Viral Entry Inhibitors